Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment. (2019)
Attributed to:
Peptide conjugated oligonucleotides for a phase I/IIa clinical trial in Spinal Muscular Atrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddy346
PubMed Identifier: 30281092
Publication URI: http://europepmc.org/abstract/MED/30281092
Type: Journal Article/Review
Volume: 28
Parent Publication: Human molecular genetics
Issue: 3
ISSN: 0964-6906